NIH Closes Doors for Secret Grant Reviews in November
Published Date: 9/26/2025
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in November 2025 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding, ensuring their confidential info stays private. No direct money changes are announced, but these reviews help decide who gets research grants.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Grant Application Reviews Scheduled Nov–Dec 2025
The NIH Center for Scientific Review will hold multiple closed virtual meetings on specific dates in November and December 2025 (for example, November 5; November 13–14; November 14; November 18–19; November 19; November 25; December 1; December 3–4; December 4–5; December 9; December 9–10; December 10–11; December 15). These meetings are set to review and evaluate grant applications, including several panels labeled 'Small Business,' so researchers and small businesses seeking NIH grant funding are affected by when their applications will be reviewed.
Applicant Confidentiality Protected
The listed Center for Scientific Review meetings in November–December 2025 are closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) so grant applications may disclose confidential trade secrets, commercial property (including patentable material), and personal information without public disclosure. You (researchers or small businesses applying for NIH grants) will have your confidential application information kept private during these review meetings.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11892 — Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
The National Cancer Institute wants your thoughts on a new way to track and locate cancer research samples through their Specimen Resource Locator. This affects researchers and labs who use these samples, aiming to make finding and sharing easier without adding extra costs or delays. You’ve got 60 days to share your feedback and help shape this helpful tool!
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Previous / Next Documents
Previous: 2025-18689 — Silicon Metal From Australia: Preliminary Affirmative Countervailing Duty Determination, and Alignment of Final Determination With Final Antidumping Duty Determination
The U.S. says Australian silicon metal producers are getting unfair government help, so it’s starting to add extra fees to their products. This affects Aussie exporters and U.S. buyers, aiming to keep things fair in the market. Final decisions will line up with other trade checks and happen soon, so stay tuned!
Next: 2025-18692 — Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Development of Zika Virus Strains for Use in Oncolytic Therapy
The National Institute of Allergy and Infectious Diseases is planning to give Advocate Aurora Research Institute in Milwaukee the exclusive rights to use special Zika virus strains for cancer-fighting treatments. This means Advocate Aurora can develop and sell these new therapies, potentially speeding up cancer care innovations. The deal could bring exciting medical advances and new business opportunities soon!